close crossing 52 week high

- New 52-Week High: The stock has surpassed its previous 52-week high, demonstrating robust upward momentum. - Strong Bullish Trend: The stock's price action suggests a strong bullish trend, with the potential for further gains. - Outperforming the Sector: Glenmark Pharmaceuticals has been outperforming the sector, making it a top player in the pharma industry. - Consistent Growth: The company has shown consistent growth, with a significant increase in its stock price over the past year. - Market Capitalization: Glenmark Pharmaceuticals has a market capitalization of ₹61,563.52 Cr, indicating a stable and established presence in the industry. Disclaimer: Investing and Trading in Stock Market is risky activity. Always trade with a stop loss. Do not Trade's invest by taking loan and trade only with the money that you can afford to risk. Do not put your entire capital in one single Trade.